Patient Registries’ Impact On Clinical Trials Debated At IoM, CMS Meetings

The growing use of patient registries is sparking debate on how they impact participation in randomized clinical trials, long considered the gold standard for any kind of medical data gathering

More from Archive

More from Pink Sheet